INVEX Therapeutics Ltd
IXC•Health Care•Biotechnology•Last updated: Dec 25
About
INVEX Therapeutics Ltd is a biopharmaceutical company focused on the development of treatments for neurological conditions. The company is primarily engaged in the research and development of its lead product, Presendin, which is aimed at treating idiopathic intracranial hypertension (IIH). INVEX collaborates with research institutions to advance its clinical trials and regulatory approvals.
Share Price Chart
Company Details
- Sector
- Health Care
- Industry
- Biotechnology
- ASX Code
- IXC
Related Shares
Investor Resources
Should you buy INVEX Therapeutics Ltd right now?
While IXC looks interesting right now, our experts have just put together a full report on the ultimate ASX investment portfolio - designed for growth and passive income.
Join the Rask weekly investment newsletter to get the names, right now